Hadron Energy (HDRN) Registration filing summary

Company overview and business model

• Hadron Halo is a planned 10-MWe, 35-MWth pressurized light-water microreactor, factory-fabricated for transport and designed for a 10-year operating cycle without refueling.

• Target uses include data centers, industrial facilities, remote communities, defense installations and utilities; the strategy prioritizes behind-the-meter and off-grid deployments.

• Planned energy-as-a-service model centers on long-term PPAs at a target $0.15/kWh; the business would own and operate units and include operations, maintenance, fuel management and decommissioning.

• NRC engagement began in 2025; the QAPD topical report received an acceptable safety evaluation in May 2026, and manufacturing and combined license submissions are targeted for 2027–2028.

• First deployment is targeted for 2030, subject to regulatory approval; plans call for U.S. production capacity of at least 50 units annually by 2035 and 100 by 2040.

Financial performance and metrics

• FY2025: revenue $0; net loss $71.8M; operating cash outflow $3.9M; cash $1.76M and accumulated deficit $72.4M at Dec. 31, 2025.

• Q1 2026: net income $13.37M versus net loss $0.22M YoY, driven mainly by non-cash SAFE remeasurement gain of $13.42M and legal-settlement remeasurement gain of $4.69M.

• Q1 2026 operating cash outflow was $1.21M; cash was $2.13M and accumulated deficit $59.0M at Mar. 31, 2026.

• Management identified substantial doubt about ability to continue as a going concern; additional financing is needed to fund development and operations.

Use of proceeds and capital allocation

• No proceeds from selling-securityholder resales; up to ~$333M could come from cash exercise of all warrants, but proceeds depend on exercise and share price.

• Warrant proceeds, if received, are expected to fund general corporate purposes and working capital; cashless exercises yield no cash.

• Business-combination closing generated ~$33.9M net proceeds after redemptions; $5.9M was paid at closing under a forward stock purchase agreement.

• Planned R&D spending totals ~$100M through 2030 for design, prototypes, testing, licensing and FOAK development; future growth financing may include equity, debt and DOE programs.